{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:45:43Z","timestamp":1791413143547,"version":"4.3.3"},"reference-count":29,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["75N93023D00001"],"award-info":[{"award-number":["75N93023D00001"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["75N93024F00004"],"award-info":[{"award-number":["75N93024F00004"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Medical Primatology"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    This session of the\n                    <jats:italic>NHP Models for HIV Prevention and Treatment: Towards Developing Pediatric Formulations<\/jats:italic>\n                    workshop focused on preclinical and translational perspectives in HIV research, with an emphasis on neonatal and infant populations. This review described the outputs of this workshop session, highlighting two key strategies to advance HIV treatment and prevention in young children: the development of novel long\u2010acting (LA) antiretroviral (ARV) formulations for children living with HIV (CLWH) and the implementation of immune\u2010based interventions to prevent vertical HIV transmission. Both approaches demonstrate the critical importance and value of preclinical studies in nonhuman primate (NHP) models to support the advancement of these technologies, with the ultimate goal of improved health outcomes in pediatric populations.\n                  <\/jats:p>","DOI":"10.1111\/jmp.70090","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T08:49:23Z","timestamp":1781858963000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Current Landscape of Neonatal\/Infant\n                    <scp>HIV<\/scp>\n                    Research: Preclinical and Translational Perspectives"],"prefix":"10.1111","volume":"55","author":[{"given":"L. M.","family":"Johnson","sequence":"first","affiliation":[{"name":"RTI International  Durham North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1509-5092","authenticated-orcid":false,"given":"E. H.","family":"Luecke","sequence":"additional","affiliation":[{"name":"RTI International  Durham North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. A.","family":"Norton","sequence":"additional","affiliation":[{"name":"RTI International  Durham North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0291-5111","authenticated-orcid":false,"given":"M. L.","family":"Cottrell","sequence":"additional","affiliation":[{"name":"Eshelman School of Pharmacy University of North Carolina  Chapel Hill North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Fouda","sequence":"additional","affiliation":[{"name":"Cornell University  New York New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"key":"e_1_2_9_2_1","volume-title":"Child Development","author":"Beltre G M. M.","year":"2025"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13809"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25049"},{"issue":"4","key":"e_1_2_9_5_1","article-title":"Formulation Challenges and Strategies to Develop Pediatric Dosage Forms","volume":"9","author":"Malkawi W. A.","year":"2022","journal-title":"Children (Basel)"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-024-04515-8"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2022.0087"},{"key":"e_1_2_9_8_1","unstructured":"DoHaH. Panel on Treatment of HIV During Pregnancy and Prevention of Perinatal Transmission \u201cRecommendations for the Use of Antiretroviral Drugs During Pregnancy and Interventions to Reduce Perinatal HIV Transmission in the United States \u201d(2026) https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/perinatal."},{"key":"e_1_2_9_9_1","unstructured":"(UNAIDS) \u201cFact sheet 2024\u2010Global HIV Statistics \u201d(2024) https:\/\/www.unaids.org\/en\/resources\/fact\u2010sheet."},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.121501"},{"key":"e_1_2_9_11_1","unstructured":"Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV \u201cGuidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection \u201dDepartment of Health and Human Services accessed June 2026 https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/pediatric\u2010arv."},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/1654938"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.106220"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2020.1783233"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.115009"},{"key":"e_1_2_9_16_1","volume-title":"Conference on Retroviruses and Oportunistic Infections (CROI)","author":"Archary M.","year":"2025"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17010113"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13365-023-01162-y"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15122676"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkac252"},{"key":"e_1_2_9_21_1","volume-title":"Paper Presented at: International AIDS Society","author":"Cottrell M. L. K.","year":"2023"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-018-0235-4"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00268-21"},{"key":"e_1_2_9_24_1","volume-title":"IMPAACT 2008. Phase I\/II Multisite, Randomized, Controlled Study of Monoclonal Antibody VRC01 With Combination Antiretroviral Therapy to Promote Clearance of HIV\u20101\u2010Infected Cells in Infants","author":"ClinicalTrials.gov","year":"2017"},{"key":"e_1_2_9_25_1","unstructured":"National Institute of Allergy and Infectious Disease (NIAID) \u201cEvaluating the Safety and Pharmacokinetics of VRC01 VRC01LS and VRC07\u2010523LS Potent Anti\u2010HIV Neutralizing Monoclonal Antibodies in HIV\u20101\u2010Exposed Infants \u201d(2023)."},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01953-6"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2019.08.014"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002739"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0312411"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adm7097"}],"container-title":["Journal of Medical Primatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jmp.70090","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jmp.70090","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jmp.70090","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T04:14:23Z","timestamp":1787199263000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jmp.70090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1111\/jmp.70090"],"URL":"https:\/\/doi.org\/10.1111\/jmp.70090","archive":["Portico"],"relation":{},"ISSN":["0047-2565","1600-0684"],"issn-type":[{"value":"0047-2565","type":"print"},{"value":"1600-0684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"2025-12-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70090"}}